Recognition and diagnosis of sleep disorders in Parkinson's disease

Journal of Neurology

Volumn 259, Issue 10, 2012, Pages 2031-2040

  Louter, Maartje ^a,b   Aarden, Willemijn C C A ^a,b   Lion, Joy ^b   Bloem, Bastiaan R ^b   Overeem, Sebastiaan ^a,b  

^a EPILEPSY CENTER KEMPENHAEGHE   (Netherlands)

^b RADBOUD UNIVERSITY   (Netherlands)

Author keywords

Excessive daytime sleepiness; Parkinson's disease; Polysomnography; Sleep disorders

Indexed keywords

APOMORPHINE; CARBIDOPA PLUS LEVODOPA; CLONAZEPAM; DOPAMINE RECEPTOR STIMULATING AGENT; GABAPENTIN; LEVODOPA; MELATONIN; METHYLPHENIDATE; MODAFINIL; OPIATE; ROTIGOTINE;

ANAMNESIS; ANXIETY; CLINICAL EXAMINATION; COGNITIVE DEFECT; DAYTIME SOMNOLENCE; DEMENTIA; DEPRESSION; DIAGNOSTIC TEST; DRUG DOSE INCREASE; DYSKINESIA; EARLY DIAGNOSIS; EPWORTH SLEEPINESS SCALE; EVENING DOSAGE; FATIGUE; HALLUCINATION; HUMAN; HYPERSOMNIA; INAPPROPRIATE SLEEP COMPOSITE SCORE; INSOMNIA; MEDICAL SPECIALIST; MULTIPLE SLEEP LATENCY TEST; NIGHT SLEEP; NIGHTMARE; NOCTURIA; NOCTURNAL STRIDOR; PARASOMNIA; PARKINSON DISEASE; PARKINSON DISEASE SLEEP SCALE; PERIODIC LIMB MOVEMENT DISORDER; PITTSBURGH SLEEP QUALITY INDEX; POLYSOMNOGRAPHY; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RATING SCALE; RESTLESS LEGS SYNDROME; REVIEW; SCALE FOR OUTCOMES IN PARKINSON DISEASE SLEEP; SLEEP DISORDER; SLEEP DISORDERED BREATHING; STRIDOR; TRACHEOTOMY; UNIFIED PARKINSON DISEASE RATING SCALE;

HUMANS; PARKINSON DISEASE; SLEEP DISORDERS;

EID: 84867330933     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-012-6505-7     Document Type: Review

References (73)

1. Adler CH, Caviness JN, Hentz JG, Lind M, Tiede J (2003) Randomized trial of modafinil for treating subjective daytime sleepiness in patients with Parkinson's disease. Mov Disord 18:287-293
2. Allen RP, Picchietti D, Hening WA, Trenkwalder C, Walters AS, Montplaisi J (2003) Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med 4:101-119
3. Arnulf I, Konofal E, Merino-Andreu M, Houeto JL, Mesnage V, Welter ML, Lacomblez L, Golmard JL, Derenne JP, Agid Y (2002) Parkinson's disease and sleepiness: an integral part of PD. Neurology 58:1019-1024
4. Barone P, Amboni M, Vitale C, Bonavita V (2004) Treatment of nocturnal disturbances and excessive daytime sleepiness in Parkinson's disease. Neurology 63:S35-S38
5. Baumann C, Ferini-Strambi L, Waldvogel D, Werth E, Bassetti CL (2005) Parkinsonism with excessive daytime sleepiness-a narcolepsy-like disorder? J Neurol 252:139-145
6. Boeve BF, Silber MH, Ferman TJ (2003) Melatonin for treatment of REM sleep behavior disorder in neurologic disorders: results in 14 patients. Sleep Med 4:281-284
7. Bossenbroek L, Kosse N, Ten Hacken N, Gordijn M, Van der Hoeven J, De Greef M (2010) Validation of the DynaPort MiniMod during sleep: a pilot study. Percept Mot Skills 111:936-946
8. Buysse DJ, Reynolds CF 3rd, Monk TH, Berman SR, Kupfer DJ (1989) The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 28:193-213
9. Carrier J, Frenette S, Montplaisir J, Paquet J, Drapeau C, Morettini J (2005) Effects of periodic leg movements during sleep in middle-aged subjects without sleep complaints. Mov Disord 20:1127-1132
10. Chaudhuri KR, Pal S, DiMarco A, Whately-Smith C, Bridgman K, Mathew R, Pezzela FR, Forbes A, Hogl B, Trenkwalder C (2002) The Parkinson's disease sleep scale: a new instrument for assessing sleep and nocturnal disability in Parkinson's disease. J Neurol Neurosurg Psychiatry 73:629-635
11. Chaudhuri KR, Prieto-Jurcynska C, Naidu Y, Mitra T, Frades-Payo B, Tluk S, Ruessmann A, Odin P, Macphee G, Stocchi F, Ondo W, Sethi K, Schapira AH, Martinez Castrillo JC, Martinez-Martin P (2010) The nondeclaration of nonmotor symptoms of Parkinson's disease to health care professionals: an international study using the nonmotor symptoms questionnaire. Mov Disord 25:697-701
12. Chrisp P, Mammen GJ (1991) Selegiline. A review of its pharmacology, symptomatic benefits and protective potential in Parkinson's disease. Drugs Aging 1:228-248
13. Claassen DO, Josephs KA, Ahlskog JE, Silber MH, Tippmann-Peikert M, Boeve BF (2010) REM sleep behavior disorder preceding other aspects of synucleinopathies by up to half a century. Neurology 75:494-499
14. Cochen De Cock V, Abouda M, Leu S, Oudiette D, Roze E, Vidailhet M, Similowski T, Arnulf I (2010) Is obstructive sleep apnea a problem in Parkinson's disease? Sleep Med 11:247-252
15. Comella CL, Nardine TM, Diederich NJ, Stebbins GT (1998) Sleep-related violence, injury, and REM sleep behavior disorder in Parkinson's disease. Neurology 51:526-529
16. De Cock VC, Vidailhet M, Leu S, Texeira A, Apartis E, Elbaz A, Roze E, Willer JC, Derenne JP, Agid Y, Arnulf I (2007) Restoration of normal motor control in Parkinson's disease during REM sleep. Brain 130:450-456
17. Eisensehr I, van Lindeiner H, Jager M, Noachtar S (2001) REM sleep behavior disorder in sleep-disordered patients with versus without Parkinson's disease: is there a need for polysomnography? J Neurol Sci 186:7-11
18. Fabbrini G, Barbanti P, Aurilia C, Vanacore N, Pauletti C, Meco G (2002) Excessive daytime sleepiness in de novo and treated Parkinson's disease. Mov Disord 17:1026-1030
19. Factor SA, McAlarney T, Sanchez-Ramos JR, Weiner WJ (1990) Sleep disorders and sleep effect in Parkinson's disease. Mov Disord 5:280-285
20. Frauscher B, Iranzo A, Hogl B, Casanova-Molla J, Salamero M, Gschliesser V, Tolosa E, Poewe W, Santamaria J (2008) Quantification of electromyographic activity during REM sleep in multiple muscles in REM sleep behavior disorder. Sleep 31:724-731
21. Friedman JH, Brown RG, Comella C, Garber CE, Krupp LB, Lou J-S, Marsh L, Nail L, Shulman L, Taylor CB (2007) Fatigue in Parkinson's disease: a review. Mov Disord 22:297-308
22. Fronczek R, Overeem S, Lee SY, Hegeman IM, van Pelt J, van Duinen SG, Lammers GJ, Swaab DF (2007) Hypocretin (orexin) loss in Parkinson's disease. Brain 130:1577-1585
23. Frucht S, Rogers JD, Greene PE, Gordon MF, Fahn S (1999) Falling asleep at the wheel: motor vehicle mishaps in persons taking pramipexole and ropinirole. Neurology 52:1908-1910
24. Gagnon JF, Bedard MA, Fantini ML, Petit D, Panisset M, Rompre S, Carrier J, Montplaisir J (2002) REM sleep behavior disorder and REM sleep without atonia in Parkinson's disease. Neurology 59:585-589
25. Garcia-Borreguero D, Larrosa O, Bravo M (2003) Parkinson's disease and sleep. Sleep med rev 7:115-129
26. Ghorayeb I, Yekhlef F, Bioulac B, Tison F (2005) Continuous positive airway pressure for sleep-related breathing disorders in multiple system atrophy: long-term acceptance. Sleep Med 6:359-362
27. Ghorayeb I, Loundou A, Auquier P, Dauvilliers Y, Bioulac B, Tison F (2007) A nationwide survey of excessive daytime sleepiness in Parkinson's disease in France. Mov Disord 22:1567-1572
28. Gjerstad MD, Boeve B, Wentzel-Larsen T, Aarsland D, Larsen JP (2008) Occurrence and clinical correlates of REM sleep behaviour disorder in patients with Parkinson's disease over time. J Neurol Neurosurg Psychiatry 79:387-391
29. Happe S, Berger K, Investigators FS (2001) The association of dopamine agonists with daytime sleepiness, sleep problems and quality of life in patients with Parkinson's disease-a prospective study. J Neurol 248:1062-1067
30. Hobson DE, Lang AE, Martin WRW, Razmy A, Rivest J, Fleming J (2002) Excessive daytime sleepiness and sudden-onset sleep in Parkinson disease: a survey by the Canadian movement disorders group. JAMA 287:455-463
31. Hogl B, Arnulf I, Comella C, Ferreira J, Iranzo A, Tilley B, Trenkwalder C, Poewe W, Rascol O, Sampaio C, Stebbins GT, Schrag A, Goetz CG (2010) Scales to assess sleep impairment in Parkinson's disease: critique and recommendations. Mov Disord 25:2704-2716
32. Iranzo A, Frauscher B, Santos H, Gschliesser V, Ratti L, Falkenstetter T, Sturner C, Salamero M, Tolosa E, Poewe W, Santamaria J, Hogl B (2011) Usefulness of the SINBAR electromyographic montage to detect the motor and vocal manifestations occurring in REM sleep behavior disorder. Sleep Med 12:284-288
33. Iranzo A, Molinuevo JL, Santamaria J, Serradell M, Marti MJ, Valldeoriola F, Tolosa E (2006) Rapid-eye-movement sleep behaviour disorder as an early marker for a neurodegenerative disorder: a descriptive study. Lancet Neurol 5:572-577
34. Iranzo A, Santamaria J (2005) Severe obstructive sleep apnea/hypopnea mimicking REM sleep behavior disorder. Sleep 28:203-206
35. Iranzo A, Santamaria J, Tolosa E (2000) Continuous positive air pressure eliminates nocturnal stridor in multiple system atrophy. Barcelona Multiple System Atrophy Study Group. Lancet 356:1329-1330
36. Iranzo A, Santamaria J, Tolosa E, et al (2004) Long-term effect of CPAP in the treatment of nocturnal stridor in multiple system atrophy. Neurology 63:930-932
37. Jansen EN, Meerwaldt JD (1988) Madopar HBS in Parkinson patients with nocturnal akinesia. Clin neurol neurosurgery 90:35-39
38. Johns MW (1991) A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 14:540-545
39. Korner Y, Meindorfner C, Moller JC, Stiasny-Kolster K, Haja D, Cassel W, Oertel WH, Kruger HP (2004) Predictors of sudden onset of sleep in Parkinson's disease. Mov Disord 19:1298-1305
40. Kwon DY, Seo WK, Yoon HK, Park MH, Koh SB, Park KW (2010) Transcranial brain sonography in Parkinson's disease with restless legs syndrome. Mov Disord 25:1373-1378
41. Lees AJ, Blackburn NA, Campbell VL (1988) The nighttime problems of Parkinson's disease. Clin Neuropharmacol 11:512-519
42. Magalhaes M, Wenning GK, Daniel SE, Quinn NP (1995) Autonomic dysfunction in pathologically confirmed multiple system atrophy and idiopathic Parkinson's disease-a retrospective comparison. Acta Neurol Scand 91:98-102
43. Marinus J, Visser M, van Hilten JJ, Lammers GJ, Stiggelbout AM (2003) Assessment of sleep and sleepiness in Parkinson disease. Sleep 26:1049-1054
44. Menza M, Dobkin RD, Marin H, Bienfait K (2010) Sleep disturbances in Parkinson's disease. Mov Disord 25(Suppl 1):S117-S122
45. Montplaisir J, Gagnon JF, Fantini ML, Postuma RB, Dauvilliers Y, Desautels A, Rompre S, Paquet J (2010) Polysomnographic diagnosis of idiopathic REM sleep behavior disorder. Mov Disord 25:2044-2051
46. Nausieda PA, Weiner WJ, Kaplan LR, Weber S, Klawans HL (1982) Sleep disruption in the course of chronic levodopa therapy: an early feature of the levodopa psychosis. Clin Neuropharmacol 5:183-194
47. Obeso JA, Grandas F, Vaamonde J, Luquin MR, Artieda J, Lera G, Rodriguez ME, Martinez-Lage JM (1989) Motor complications associated with chronic levodopa therapy in Parkinson's disease. Neurology 39:11-19
48. Ondo WG, Dat Vuong K, Khan H, Atassi F, Kwak C, Jankovic J (2001) Daytime sleepiness and other sleep disorders in Parkinson's disease. Neurology 57:1392-1396
49. Ondo WG, Vuong KD, Jankovic J (2002) Exploring the relationship between Parkinson disease and restless legs syndrome. Arch Neurol 59:421-424
50. Overeem S, van Hilten JJ, Ripley B, Mignot E, Nishino S, Lammers GJ (2002) Normal hypocretin-1 levels in Parkinson's disease patients with excessive daytime sleepiness. Neurology 58:498-499
51. Paus S, Brecht HM, Koster J, Seeger G, Klockgether T, Wullner U (2003) Sleep attacks, daytime sleepiness, and dopamine agonists in Parkinson's disease. Mov Disord 18:659-667
52. Poryazova R, Benninger D, Waldvogel D, Bassetti CL (2010) Excessive daytime sleepiness in Parkinson's disease: characteristics and determinants. Eur Neurol 63:129-135
53. Puca FM, Bricolo A, Turella G (1973) Effect of L-dopa or amantadine therapy on sleep spindles in Parkinsonism. Electroencephalogr Clin Neurophysiol 35:327-330
54. Qin Z, Zhang L, Sun F, Fang X, Meng C, Tanner C, Chan P (2009) Health related quality of life in early Parkinson's disease: impact of motor and non-motor symptoms, results from Chinese levodopa exposed cohort. Parkinsonism Relat Disord 15:767-771
55. Rahman S, Griffin HJ, Quinn NP, Jahanshahi M (2008) Quality of life in Parkinson's disease: the relative importance of the symptoms. Mov Disord 23:1428-1434
56. Reuter I, Ellis CM, Ray Chaudhuri K (1999) Nocturnal subcutaneous apomorphine infusion in Parkinson's disease and restless legs syndrome. Acta neurologica Scandinavica 100:163-167
57. Ryu JH, Lee MS, Baik JS (2011) Sonographic abnormalities in idiopathic restless legs syndrome (RLS) and RLS in Parkinson's disease. Parkinsonism Relat Disord 17:201-203
58. Scaravilli T, Gasparoli E, Rinaldi F, Polesello G, Bracco F (2003) Health-related quality of life and sleep disorders in Parkinson's disease. Neurol Sci 24:209-210
59. Schenck C, Mahowald M (1990) Polysomnographic, neurologic, psychiatric, and clinical outcome report of 70 consecutive cases with REM sleep behavior disorder (RBD): sustained clonazepam efficacy in 89.5% of 57 treated patients. Clev Clin J Med 57:10-24
60. Scofield H, Roth T, Drake C (2008) Periodic limb movements during sleep: population prevalence, clinical correlates, and racial differences. Sleep 31:1221-1227
61. Silber MH, Levine S (2000) Stridor and death in multiple system atrophy. Mov Disord 15:699-704
62. Sixel-Doring F, Schweitzer M, Mollenhauer B, Trenkwalder C (2011) Intraindividual variability of REM sleep behavior disorder in Parkinson's disease: a comparative assessment using a new REM sleep behavior disorder severity scale (RBDSS) for clinical routine. J Clin Sleep Med 7:75-80
63. Tandberg E, Larsen JP, Karlsen K (1998) A community-based study of sleep disorders in patients with Parkinson's disease. Mov Disord 13:895-899
64. Tandberg E, Larsen JP, Karlsen K (1999) Excessive daytime sleepiness and sleep benefit in Parkinson's disease: a communitybased study. Mov Disord 14:922-927
65. Thannickal TC, Lai YY, Siegel JM (2007) Hypocretin (orexin) cell loss in Parkinson's disease. Brain 130:1586-1595
66. Trenkwalder C, Kohnen R, Hogl B, Metta V, Sixel-Doring F, Frauscher B, Hulsmann J, Martinez-Martin P, Chaudhuri KR (2011) Parkinson's disease sleep scale-validation of the revised version PDSS-2. Mov Disord 26:644-652
67. Trenkwalder C, Kies B, Rudzinska M, et al (2011) Rotigotine effects on early morning motor function and sleep in Parkinson's disease: a double-blind, randomized, placebo-controlled study (RECOVER). Mov Disord 26:90-99
68. Trotti LM, Bliwise DL (2010) No increased risk of obstructive sleep apnea in Parkinson's disease. Mov Disord 25:2246-2249
69. Valko PO, Waldvogel D, Weller M, Bassetti CL, Held U, Baumann CR (2010) Fatigue and excessive daytime sleepiness in idiopathic Parkinson's disease differently correlate with motor symptoms, depression and dopaminergic treatment. Eur J Neurol 17:1428-1436
70. Verbaan D, van Rooden SM, van Hilten JJ, Rijsman RM (2010) Prevalence and clinical profile of restless legs syndrome in Parkinson's disease. Mov Disord 25:2142-2147
71. Wetter TC, Collado-Seidel V, Pollmacher T, Yassouridis A, Trenkwalder C (2000) Sleep and periodic leg movement patterns in drug-free patients with Parkinson's disease and multiple system atrophy. Sleep 23:361-367
72. Yamaguchi M, Arai K, Asahina M, Hattori T (2003) Laryngeal stridor in multiple system atrophy. Eur Neurol 49:154-159
73. Yasui K, Inoue Y, Kanbayashi T, Nomura T, Kusumi M, Nakashima K (2006) CSF orexin levels of Parkinson's disease, dementia with Lewy bodies, progressive supranuclear palsy and corticobasal degeneration. J Neurol Sci 250:120-123